SY-007

N/A

Report date: 2026/02/06 09:27:26
NMEFirst In Class

Base Information

Drug NameSY-007
Drug Alias NameK13 peptideK-13
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN inhibitors
TargetsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
Therapy Area/IndicationsIschemic StrokeStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesPrimary Peptides Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesYabao Pharmaceutical Group Co LtdSuzhou Yabao Pharmaceutical R&D Co Ltd
Active IndicationsN/A
Inactive IndicationsIschemic StrokeStroke

Other Information

ATC CodeN/A
Related LinksN/A